Dagelijkse dosering: 2 capsules DR Caps™
Aantal doses per potje: 45 |
Hoeveelheid per dosis |
| Serrapeptase (fijne maagzuurbestendige korreltjes met Serratia peptidase 2 000 eenheden/mg) |
120 000 IE |
Overige ingrediënten: Acaciagom
bevat lactose
|
Volwassenen. Neem tweemaal daags een capsule op de lege maag.
Elke DR Caps™ bevat 30 mg serrapeptase.
- Mazzone, M. Catalani, M. Costanzo, A. Drusian, A. Mandoli, S. Russo, et al.Evaluation of Serratia-peptidase in acute or chronic inflammation of otorhinolaryngology pathology: a multicentre, double-blind, randomized trial versus placebo, J Int Med Res, 18 (1990), pp. 379-388
- H. Yamasaki, H. Tsuji, K. Siki Anti-inflammatory action of a protease, TSP, produced by serratia, Folia Pharmacol Japan, 63 (1967), pp. 302-314
- G. Klein, W. Kullich, Short-term treatment of painful osteoarthritis of the knee with oral enzymes. A randomized, double-blind study versus diclofenac, Clin Drug Invest, 19 (2000), pp. 15-23
- Shivani Bhagat, MonikaAgarwal, Vandana Roy. Serratiopeptidase: A systematic review of the existing evidence, International Journal of Surgery, Volume 11, Issue 3, April 2013, Pages 209-217, https://doi.org/10.1016/j.ijsu.2013.01.010
- P. Libby, Inflammatory mechanisms: the molecular basis of inflammation and disease, Nutr Rev, 65 (12 Pt 2) (2007), pp. S140-S146
- C.N. Serhan, Novel chemical mediators in the resolution of inflammation: resolvins and protectins, Anesthesiol Clin, 24 (2) (2006), pp. 341-364
- G.L. Bannenberg, Resolvins: current understanding and future potential in the control of inflammation, Curr Opin Drug Discov Devel, 12 (5) (2009), pp. 644-658
- G. Klein, W. Kullich, Short-term treatment of painful osteoarthritis of the knee with oral enzymes. A randomized, double-blind study versus diclofenac, Clin Drug Invest, 19 (2000), pp. 15-23
- N. Moriya, A. Shoichi, H. Yoko, H. Fumio, K. Yoshiaki, Intestinal absorption of serrapeptase and its distribution to the inflammation sites, Japan Pharmacol Therap, 31 (2003), pp. 659-666
- N. Moriya, M. Nakata, M. Nakamuma, M. Takaoka, S. Iwasa, K. Kato, et al. Intestinal absorption of serrapeptase (TSP) in rats, Biotechnol Appl Biochem, 20 (1994), pp. 101-108
- S.P. Jadav, N.H. Patel, T.G. Shah, et al. Comparison of anti-inflammatory activity of serratiopeptidase and diclofenac in albino rats. J Pharmacol Pharmacother, 1 (2) (2010), pp. 116-117, 10.4103/0976-500X.72362
- M.M. Bodhankar, V.V. Agnihotri, S.B. Bhushan, Feasibility, formulation and characterization of innovative microparticles for oral delivery of peptide drug, Int J Res Pharm Chem, 1 (2011), pp. 630-636
- Bhagat S, et al., Serratiopeptidase: A systematic review of the existing evidence, International Journal of Surgery (2013), https://dx.doi.org/10.1016/j.ijsu.2013.01.010
